drugset / Trial / NCT01453634
Four Week, Pharmacodynamic/Pharmacokinetic, Efficacy, and Safety Study of Lunacalcipol (CTA018)
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Open-label, pharmacodynamic, safety, pharmacokinetic and efficacy study of Lunacalcipol Injection.
Timeline
- Start
- 2013-01
- Primary completion
- 2013-07
- Completion
- 2013-07
Outcome
Outcome not reported
Stopped: “The company is no longer pursuing this study.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lunacalcipol | Small molecule | 180 ug | — |
| Subject | Lunacalcipol | Small molecule | 270 ug | — |